BML, Inc. (TYO:4694)

Market Cap	140.38B -0.5%
Revenue (ttm)	151.27B +3.9%
Net Income	7.87B +22.6%
EPS	208.64 +26.8%
Shares Out	37.48M
PE Ratio	17.95
Forward PE	18.11
Dividend	125.00 (3.34%)
Ex-Dividend Date	Sep 29, 2026

Volume	14,600
Open	3,780.00
Previous Close	3,775.00
Day's Range	3,720.00 - 3,780.00
52-Week Range	3,370.00 - 4,385.00
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2026

About BML, Inc.

BML, Inc. provides contract clinical testing and related services in Japan. The company offers routine laboratory testing, such as biochemical and hematologic examination; special laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to ...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1955
• Employees: 4,612
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4694

Financial Performance

In fiscal year 2026, BML, Inc.'s revenue was 150.26 billion, an increase of 4.94% compared to the previous year's 143.19 billion. Earnings were 7.75 billion, an increase of 23.71%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 29, 2026

Data Sources Report a data error